Introduction: Thalassemia could interfere with some assays for haemoglobin A 1c (HbA 1c fraction; for the remaining 95 thalassaemia samples, Bland-Altman plot showed 0.00 ± 0.35% absolute bias between two systems, and a significant positive bias above 7% was observed only in two HbH samples. The HbA 1c values obtained by Capillarys 2FP were consistent with the IFCC targets (relative bias below ± 6%) in all of the eight samples tested by both methods. For screening samples with alpha (α-) thalassaemia silent/trait or beta (β-) thalassemia trait, the optimal HbA 2 cut-off values were ≤ 2.2% and > 2.8%, respectively. Conclusions: Our results demonstrated the Capillarys 2FP HbA 1c system could report an accurate HbA 1c value in thalassemia silent/trait, and HbA 2 value (≤ 2.2% for α-thalassaemia silent/trait and > 2.8% for β-thalassemia trait) and abnormal bands (HbH and/or HbBart's for HbH disease, HbF for β-thalassemia) may provide valuable information for screening.
Introduction
Haemoglobin A 1c (HbA 1c ), the major form of all glycated haemoglobin species, is produced by the non-enzymatic addition of glucose residues to valine moieties at the N-terminal end of the haemoglobin (Hb) β-chain (1) . HbA 1c concentrations are used as an index for long-term glycaemic control, and have recently been recommended for the diagnosis of diabetes mellitus (2) (3) (4) . Various methods have been developed to measure HbA 1c , however, their accuracy can be adversely affected by the presence of haemoglobinopathies (5, 6) . In addition, HbA 1c provides an estimate of blood glucose concentrations over a normal erythrocyte lifespan, and any conditions altering erythrocyte survival (e.g., haemolytic anaemia, iron deficiency anaemia or haemoglobinopathies) may lead to misinterpretation of the HbA 1c result and hence misdiagnosis and mistreatment (7) . Thalassemia is the most common monogenetic disease caused by defects in the synthesis of one or more of the haemoglobin chains (8, 9) . Alpha (α-) thalassemia is caused by reduced or absent synthesis of α globin chains, including four main forms: α-thalassemia silent, α-thalassemia trait (minor), HbH (intermedia) and HbBart's hydrops fetalis syndrome (major). Beta (β-) thalassemia is Ke P. et 
Materials and methods

Subjects
The Research and Ethics committees of our institution approved this study. All subjects were informed on the study contents and provided written consents for participation. Blood samples were obtained from the Clinical Laboratory of the Second Affiliated Hospital of Guangzhou University of Chinese Medicine between June 2014 and August 2014. These samples included 498 healthy adults (normal controls) and 175 patients with thalassemia. The 175 thalassemia patients included 51 with α-thalassemia silent, 57 with α-thalassemia trait, 7 with HbH and 60 with β-thalassemia trait. Whole blood samples were collected in EDTA-containing tubes (2.0 mL, BD Franklin Lakes NJ, USA), divided into small aliquots and stored at -80°C before analysis as previously described (19, 20) .
Normal control samples were selected from subjects undergoing routine laboratory check-up examinations. Complete blood count (CBC) parameters were measured with BC-6800 (Mindray Medical Electronics Co., Shenzhen, China). Inclusion criteria were as follows: Hb concentrations > 130 g/L (in men) or > 115 g/L (in women), mean corpuscular volume (MCV) > 80 fL, HbF < 5% without Hb disorders (Hb phenotype analysis was performed by Bio-Rad Variant II system (Bio-Rad, Japan) using the beta thalassemia programme). Thalassemia samples were collected from routine laboratory test samples for thalassemia. Gap-polymerase chain reaction (PCR) was used to identify the α-thalassemia deletion mutations, and PCR reverse-blot hybridization was used to detect β-thalassemia point mutations (YANENG Bioscience Co. Ltd., Shenzhen, China) (21, 22) .
Method comparison
The 
Thalassemia screening
A total of 498 normal controls and 168 thalassemia samples (51 α-thalassemia silent, 57 α-thalassemia traits, and 60 β-thalassemia traits) were analysed by Capillarys 2FP HbA 1c programme.
Statistical analysis
For method comparison, the differences between two methods (Capillarys 2FP vs Premier Hb9210) were presented in a Bland-Altman plot. The relative bias was calculated by the Capillarys 2FP value against the comparative method (Premier Hb9210) value, and > ±7% was considered clinically significant (National Glycohemoglobin Standardization Programme (NGSP) criterion) (24). For verification testing, the relative bias was calculated by the Capillarys 2FP value against the IFCC reference method value, and the proficiency testing acceptance limit of ± 6% provided by the College of American Pathologists (CAP) was set as the accuracy limit (25) .
Measurement data of HbA 2 were normally distributed and the independent sample t-test was performed to detect statistical difference between any two groups. Receiver operating characteristic curve (ROC) was applied to determine the best cut-off for screening α-and β-thalassemia. A P value of < 0.05 was considered statistically significant. Statistical analysis was performed using the MedCalc version 14.8.1 (MedCalc Software, Ostend, Belgium).
Results
Method comparison
Among the 98 thalassaemia samples, HbA 1c was not detected by Capillarys 2FP in three samples with HbH ( Figure 1 ). For the remaining 95 thalassaemia samples with detectable HbA 1c , the BlandAltman plot showed that the absolute bias of HbA 1c was 0.00 ± 0.35% between Capillarys 2FP and Premier Hb9210 systems, and 3.4% of values were discordant (i.e., differences outside the range mean ± 2SD) ( Figure 2) . A significant positive bias above 7% was found only in two HbH samples.
To validate these results, the samples of eight thalassemias including two α-thalassemia silent, two α-thalassemia trait, two HbH and two β-thalassemia trait, were analysed by IFCC reference method HPLC/CE for HbA 1c . The results showed that the HbA 1c concentrations obtained by Capillarys 2FP were consistent with the results obtained by IFCC HPLC/CE reference method, with relative bias below ± 6% (Table 1) .
Thalassemia screening
The HbA 2 concentration in α-thalassaemia silent/ trait (0.9 -2.6%) was significantly lower than normal controls (1.7 -2.8%) (P < 0.001, Figure 3A) . ROC analysis showed an area under curve (AUC) of 0.81 (95% confidence interval, 0.78 -0.84) and the optimal cut-off value was ≤ 2.2% with a sensitivity of 76.9% and specificity of 73.7% ( Figure 3B ).
The HbA 2 concentration in β-thalassaemia trait (4.0 -5.6%) was significantly higher than normal controls (1.7 -2.8%) (P < 0.001, Figure 3A) . ROC analysis demonstrated an AUC of 1.00 (95% confidence interval, 0.99 -1.00) and the optimal cut-off value was > 2.8% with sensitivity 100% and specificity 100% ( Figure 3C ).
Discussion
Our results indicate that the presence of α-thalassaemia silent/trait and β-thalassemia trait had no significant effect on the accuracy of 
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